Travere Therapeutics, Inc. (TVTX)
62.51
-3.28
(-4.99%)
USD |
NASDAQ |
Sep 15, 16:00
62.50
-0.01
(-0.02%)
After-Hours: 07:54
Travere Therapeutics Price to Book Value : 240.06 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 240.06 |
| September 14, 2026 | 252.66 |
| September 11, 2026 | 254.12 |
| September 10, 2026 | 259.26 |
| September 09, 2026 | 254.31 |
| September 08, 2026 | 253.73 |
| September 04, 2026 | 250.70 |
| September 03, 2026 | 255.54 |
| September 02, 2026 | 258.19 |
| September 01, 2026 | 252.35 |
| August 31, 2026 | 254.54 |
| August 28, 2026 | 252.20 |
| August 27, 2026 | 259.30 |
| August 26, 2026 | 257.77 |
| August 25, 2026 | 257.34 |
| August 24, 2026 | 250.47 |
| August 21, 2026 | 252.35 |
| August 20, 2026 | 247.55 |
| August 19, 2026 | 253.31 |
| August 18, 2026 | 245.40 |
| August 17, 2026 | 243.98 |
| August 14, 2026 | 238.64 |
| August 13, 2026 | 235.92 |
| August 12, 2026 | 238.72 |
| August 11, 2026 | 231.23 |
| Date | Value |
|---|---|
| August 10, 2026 | 233.84 |
| August 07, 2026 | 235.49 |
| August 06, 2026 | 239.83 |
| August 05, 2026 | 241.02 |
| August 04, 2026 | 215.14 |
| August 03, 2026 | 211.14 |
| July 31, 2026 | 214.64 |
| July 30, 2026 | 219.98 |
| July 29, 2026 | 213.37 |
| July 28, 2026 | 214.72 |
| July 27, 2026 | 217.67 |
| July 24, 2026 | 220.28 |
| July 23, 2026 | 217.67 |
| July 22, 2026 | 216.06 |
| July 21, 2026 | 217.29 |
| July 20, 2026 | 213.03 |
| July 17, 2026 | 217.79 |
| July 16, 2026 | 212.30 |
| July 15, 2026 | 217.90 |
| July 14, 2026 | 219.13 |
| July 13, 2026 | 216.18 |
| July 10, 2026 | 217.33 |
| July 09, 2026 | 224.55 |
| July 08, 2026 | 224.13 |
| July 07, 2026 | 222.17 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| TG Therapeutics, Inc. | 13.44 |
| Krystal Biotech, Inc. | 7.332 |
| RenovoRx, Inc. | 8.644 |
| Pelthos Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 3.525 |
Price to Book Value Related Metrics
| PS Ratio | 9.996 |
| Price to Free Cash Flow | 383.87 |
| Price | 62.51 |
| Earnings Yield | -1.22% |
| Market Cap | 5.887B |